Ace the ACRP Clinical Research Pro Exam 2026 – Dash into Data with Confidence!

The requirement to submit changes to an Investigator's Brochure (IB) to the Institutional Review Board (IRB) or Independent Ethics Committee (IEC) hinges on specific regulatory guidelines. When there are changes related to safety information or the scientific content that could affect the risk/benefit assessment for the study subjects, these changes must be communicated to the IRB/IEC. This ensures that the review body has the most up-to-date information regarding the study, enabling them to protect the rights and welfare of the participants.

Submitting only specific safety language changes acknowledges that certain types of information are crucial for ongoing ethical oversight. For instance, if new safety data emerges that alters the treatment's risk profile or new adverse effects are identified, these changes must be brought to the attention of the IRB/IEC. Hence, while it is essential to communicate significant updates that could impact study participants, it is not necessary to submit every minor change to the IB, as not all changes will have implications for participant safety or study integrity.